10 Hrs
Source:
وكالة الانباء العراقية (واع)
Source: وكالة الانباء العراقية (واع)
10 Hrsوكالة الانباء العراقية (واع)
Source: وكالة الانباء العراقية (واع)
10 HrsReady to play
Ready to play
Results from a clinical trial showed that an experimental drug developed by Biogen may slow cognitive decline by 38% over two years in people with early-stage Alzheimer’s, by targeting the tau protein linked to the deterioration of nerve cells.
Notice: This Is an AI-Generated Summary
Comments (0)